Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

ClinicalTrials.gov ID: NCT06627179

Public ClinicalTrials.gov record NCT06627179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 2:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Study identification

NCT ID: NCT06627179
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Laboratoires Thea; Industry
Enrollment: 81 participants

Conditions and interventions

Conditions

Interventions

Intravitreal Injection of Ultevursen Drug
No intervention, will not receive any active study intervention Other

Drug · Other

Eligibility (public fields only)

Age range: 8 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 10, 2024
Primary completion: Nov 30, 2027
Completion: Nov 30, 2027
Last update posted: Mar 29, 2026

2024 – 2027

United States locations

U.S. sites: 11
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
The University of California, San Francisco	San Francisco	California	94143	Recruiting
Bascom Palmer Eye Institute/University of Miami	Miami	Florida	33136	Recruiting
Emory University	Atlanta	Georgia	30322	Recruiting
Massachusetts Eye and Ear	Boston	Massachusetts	02114	Recruiting
University of Michigan- Kellogg Eye Center	Ann Arbor	Michigan	48105	Recruiting
Duke Eye Center	Durham	North Carolina	27705	Recruiting
Casey Eye Institute, Oregon Health & Science University	Portland	Oregon	97239	Recruiting
University of Pennsylvania, Scheie Eye Institute	Philadelphia	Pennsylvania	19104	Recruiting
Retina Foundation of the Southwest	Dallas	Texas	75231	Recruiting
Baylor College of Medicine	Houston	Texas	77030	Recruiting
University of Wisconsin- Madison	Madison	Wisconsin	53705	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06627179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 29, 2026 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06627179 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →